Mannkind (MNKD) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.04, -4.70% vs the prior close of $3.19.
- Volume 2.61M shares, 0.6x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MNKD slides 4.7% to $3.04. Closed at $3.04, -4.70% vs the prior close of $3.19. Day range $3.02–$3.24, opened at $3.20.
MNKD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MNKD slides 4.7% to $3.04
- Closed at $3.04, -4.70% vs the prior close of $3.19. Day range $3.02–$3.24, opened at $3.20.
- Volume was 2.61M shares, 0.6x its 50-day average of 4.45M — lighter than usual.
- Price is -18.5% vs its 50-day average ($3.73) and -21.1% vs its 200-day average ($3.85).
- 52-week range $2.23–$6.51; today's close sits at 19% of that range, 53.3% below the 52-week high.
Oct 15, 2026 — MNKD jumps 5.6% to $3.19
- Closed at $3.19, +5.63% vs the prior close of $3.02. Day range $3.00–$3.20, opened at $3.02.
- Volume was 3.76M shares, 0.8x its 50-day average of 4.52M.
- Price is -14.9% vs its 50-day average ($3.75) and -17.5% vs its 200-day average ($3.87).
- 52-week range $2.23–$6.51; today's close sits at 22% of that range, 51.0% below the 52-week high.
Oct 14, 2026 — MNKD dips 1.0% to $3.02, a 3-month low, 7 down days in a row
- Closed at $3.02, -0.98% vs the prior close of $3.05. Day range $2.90–$3.13, opened at $3.00.
- Volume was 7.93M shares, 1.8x its 50-day average of 4.46M.
- Price is -19.8% vs its 50-day average ($3.77) and -22.1% vs its 200-day average ($3.88).
- 52-week range $2.23–$6.51; today's close sits at 18% of that range, 53.6% below the 52-week high.
- That makes 7 straight losses.
Oct 13, 2026 — MNKD dips 2.6% to $3.05, a 3-month low, 6 down days in a row
- Closed at $3.05, -2.56% vs the prior close of $3.13. Day range $3.02–$3.14, opened at $3.13.
- Volume was 4.39M shares, 1.0x its 50-day average of 4.48M.
- Price is -19.4% vs its 50-day average ($3.78) and -21.7% vs its 200-day average ($3.89).
- 52-week range $2.23–$6.51; today's close sits at 19% of that range, 53.1% below the 52-week high.
- That makes 6 straight losses.
Oct 12, 2026 — MNKD slides 4.9% to $3.13, a 3-month low, 5 down days in a row
- Closed at $3.13, -4.86% vs the prior close of $3.29. Day range $3.08–$3.27, opened at $3.24.
- Volume was 3.96M shares, 0.9x its 50-day average of 4.51M.
- Price is -17.6% vs its 50-day average ($3.80) and -19.9% vs its 200-day average ($3.91).
- 52-week range $2.23–$6.51; today's close sits at 21% of that range, 51.9% below the 52-week high.
- That makes 5 straight losses.
Oct 9, 2026 — MNKD slides 3.8% to $3.29, 4 down days in a row
- Closed at $3.29, -3.80% vs the prior close of $3.42. Day range $3.23–$3.41, opened at $3.40.
- Volume was 4.55M shares, 1.0x its 50-day average of 4.50M.
- Price is -13.8% vs its 50-day average ($3.81) and -16.1% vs its 200-day average ($3.92).
- 52-week range $2.23–$6.51; today's close sits at 25% of that range, 49.5% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — MNKD dips 0.9% to $3.42, 3 down days in a row
- Closed at $3.42, -0.87% vs the prior close of $3.45. Day range $3.33–$3.53, opened at $3.42.
- Volume was 4.54M shares, 1.0x its 50-day average of 4.48M.
- Price is -10.7% vs its 50-day average ($3.83) and -13.1% vs its 200-day average ($3.93).
- 52-week range $2.23–$6.51; today's close sits at 28% of that range, 47.5% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — MNKD slides 7.0% to $3.45
- Closed at $3.45, -7.01% vs the prior close of $3.71. Day range $3.39–$3.68, opened at $3.67.
- Volume was 6.01M shares, 1.4x its 50-day average of 4.43M.
- Price is -10.2% vs its 50-day average ($3.84) and -12.6% vs its 200-day average ($3.95).
- 52-week range $2.23–$6.51; today's close sits at 29% of that range, 47.0% below the 52-week high.
Oct 6, 2026 — MNKD dips 2.9% to $3.71
- Closed at $3.71, -2.88% vs the prior close of $3.82. Day range $3.69–$3.86, opened at $3.86.
- Volume was 3.07M shares, 0.7x its 50-day average of 4.48M.
- Price is -3.6% vs its 50-day average ($3.85) and -6.3% vs its 200-day average ($3.96).
- 52-week range $2.23–$6.51; today's close sits at 35% of that range, 43.0% below the 52-week high.
Oct 5, 2026 — MNKD rises 0.5% to $3.82
- Closed at $3.82, +0.53% vs the prior close of $3.80. Day range $3.70–$3.85, opened at $3.82.
- Volume was 2.88M shares, 0.6x its 50-day average of 4.61M.
- Price is -0.9% vs its 50-day average ($3.85) and -3.8% vs its 200-day average ($3.97).
- 52-week range $2.23–$6.51; today's close sits at 37% of that range, 41.3% below the 52-week high.
Oct 2, 2026 — MNKD slides 3.8% to $3.80
- Closed at $3.80, -3.80% vs the prior close of $3.95. Day range $3.71–$4.01, opened at $4.01.
- Volume was 4.61M shares, 1.0x its 50-day average of 4.57M.
- Price is -1.6% vs its 50-day average ($3.86) and -4.6% vs its 200-day average ($3.98).
- 52-week range $2.23–$6.51; today's close sits at 37% of that range, 41.6% below the 52-week high.
MNKD latest news & SEC filings
Every SEC filing by or about MNKD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Binder Steven B. sold 39,051 shares at $3.29 (≈$128.48K) on Sep 25, 2026; now holds 713,258
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 25, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Binder Steven B. sold 33,558 shares at $3.81 (≈$127.86K) on Sep 10, 2026
- Binder Steven B. sold 33,558 shares at $3.81 (≈$127.86K) on Sep 10, 2026
- Binder Steven B. sold 33,558 shares at $3.81 (≈$127.86K) on Sep 10, 2026
- Binder Steven B. sold 33,558 shares at $3.81 (≈$127.86K) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 21, 2026 · Form 424B7 — Prospectus supplement for a resale by holders
Prospectus supplement for a resale by holders
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Binder Steven B. sold 39,051 shares at $4.06 (≈$158.55K) on Aug 7, 2026
- Binder Steven B. sold 39,051 shares at $4.06 (≈$158.55K) on Aug 7, 2026
- Binder Steven B. sold 39,051 shares at $4.06 (≈$158.55K) on Aug 7, 2026
- Binder Steven B. sold 39,051 shares at $4.06 (≈$158.55K) on Aug 7, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 7, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $109.37M (prior year $76.53M) (+42.9% vs Jun 30, 2025)
- Net income: -$19.03M (prior year $668.00K) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.06 (prior year $0.00)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.02 — Sold unregistered shares.
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade MNKD
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 26, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.25% (largest 16.8%). That is a volatile stock.
- Liquidity: about 5.67M shares (≈$17.25M) trade per day on average.
- 52-week position: $3.04 vs a range of $2.23–$6.51 (19% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Steven B. Binder sold 39,051 shares on Sep 25, 2026.
- Latest filings: 8-K Aug 21, 2026; 10-Q Aug 5, 2026; 8-K Aug 5, 2026.
- Share count: 321.54M shares outstanding (Jul 24, 2026), +4.8% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
MNKD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.20 | 3.24 | 3.02 | 3.04 | 2.61M |
| Oct 15, 2026 | 3.02 | 3.20 | 3.00 | 3.19 | 3.76M |
| Oct 14, 2026 | 3.00 | 3.13 | 2.90 | 3.02 | 7.93M |
| Oct 13, 2026 | 3.13 | 3.14 | 3.02 | 3.05 | 4.39M |
| Oct 12, 2026 | 3.24 | 3.27 | 3.08 | 3.13 | 3.96M |
| Oct 9, 2026 | 3.40 | 3.41 | 3.23 | 3.29 | 4.55M |
| Oct 8, 2026 | 3.42 | 3.53 | 3.33 | 3.42 | 4.54M |
| Oct 7, 2026 | 3.67 | 3.68 | 3.39 | 3.45 | 6.01M |
| Oct 6, 2026 | 3.86 | 3.86 | 3.69 | 3.71 | 3.07M |
| Oct 5, 2026 | 3.82 | 3.85 | 3.70 | 3.82 | 2.88M |
| Oct 2, 2026 | 4.01 | 4.01 | 3.71 | 3.80 | 4.61M |
| Oct 1, 2026 | 3.84 | 4.23 | 3.83 | 3.95 | 10.19M |
| Sep 30, 2026 | 3.37 | 4.03 | 3.30 | 3.90 | 15.02M |
| Sep 29, 2026 | 3.35 | 3.38 | 3.28 | 3.34 | 2.38M |
| Sep 28, 2026 | 3.34 | 3.38 | 3.28 | 3.35 | 2.08M |
| Sep 25, 2026 | 3.32 | 3.39 | 3.17 | 3.34 | 8.85M |
| Sep 24, 2026 | 3.33 | 3.33 | 3.23 | 3.29 | 2.96M |
| Sep 23, 2026 | 3.48 | 3.48 | 3.34 | 3.34 | 2.87M |
| Sep 22, 2026 | 3.53 | 3.55 | 3.26 | 3.49 | 16.30M |
| Sep 21, 2026 | 3.55 | 3.62 | 3.47 | 3.50 | 4.52M |
About Mannkind
Mannkind (MNKD) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in DANBURY, CT. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 899460.
MNKD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Steven B. Binder | Director | Sep 28, 2026 |
| Michael Castagna | Chief Executive Officer | Jul 17, 2026 |
| Ronald J Consiglio | Director | May 22, 2026 |
| Michael A Friedman | Director | May 22, 2026 |
| Jennifer Grancio | Director | May 22, 2026 |
| Anthony C Hooper | Director | May 22, 2026 |
| Sabrina Kay | Director | May 22, 2026 |
| Christine Mundkur | Director | May 22, 2026 |
| James Samuel Shannon | Director | May 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Ajay Ahuja | Chief Medical Officer | Mar 25, 2026 |
| Michael Castagna | Chief Executive Officer | Jul 17, 2026 |
| Dominic Marasco | Pres, Endocrine Business Unit | Jul 17, 2026 |
| Christopher B Prentiss | Chief Financial Officer | Jul 17, 2026 |
| Sanjay R Singh | EVP Technical Operations | Jul 17, 2026 |
| David Thomson | EVP Genl Counsel & Secretary | Jul 17, 2026 |
| Stuart A Tross | Chief People & Workpl Officer | Jul 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 25, 2026 | Steven B. Binder | Sale | 39,051 | $3.29 |
| Sep 25, 2026 | Steven B. Binder | Sale | 39,051 | $3.29 |
| Sep 25, 2026 | Steven B. Binder | Sale | 39,051 | $3.29 |
| Sep 25, 2026 | Steven B. Binder | Sale | 39,051 | $3.29 |
| Sep 10, 2026 | Steven B. Binder | Sale | 33,558 | $3.81 |
| Sep 10, 2026 | Steven B. Binder | Sale | 33,558 | $3.81 |
| Sep 10, 2026 | Steven B. Binder | Sale | 33,558 | $3.81 |
| Sep 10, 2026 | Steven B. Binder | Sale | 33,558 | $3.81 |
| Aug 7, 2026 | Steven B. Binder | Sale | 39,051 | $4.06 |
| Aug 7, 2026 | Steven B. Binder | Sale | 39,051 | $4.06 |
| Aug 7, 2026 | Steven B. Binder | Sale | 39,051 | $4.06 |
| Aug 7, 2026 | Steven B. Binder | Sale | 39,051 | $4.06 |
| Jul 17, 2026 | Steven B. Binder | Sale | 52,485 | $4.06 |
| Jul 17, 2026 | Steven B. Binder | Sale | 52,485 | $4.06 |
| Jul 17, 2026 | Steven B. Binder | Sale | 52,485 | $4.06 |
MNKD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $348.97M | $5.86M | 0.02 | $18.25M |
| Dec 31, 2024 | $285.50M | $27.59M | 0.10 | $42.51M |
| Dec 31, 2023 | $198.96M | $-11.94M | -0.04 | $34.09M |
| Dec 31, 2022 | $99.77M | $-87.40M | -0.34 | $-80.68M |
| Dec 31, 2021 | $75.44M | $-80.93M | -0.32 | $-61.71M |
Latest balance sheet: total assets $732.30M, total liabilities $799.50M, cash $52.93M (as of Jun 30, 2026).
MNKD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $4.10 |
| May 6, 2026 | 8-K Item 2.02 (results) | $3.56 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $3.24 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $6.06 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $3.47 |
| May 8, 2025 | 8-K Item 2.02 (results) | $4.63 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $5.47 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $7.39 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Feb 27, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MNKD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.